EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA IN A SUBJECT WITH SECONDARY HYPOTHYROIDISM BEARING THE APOLIPOPROTEIN E2/2 PHENOTYPE

被引:11
|
作者
FEUSSNER, G
ZIEGLER, R
机构
[1] Department of Internal Medicine I, Endocrinology and Metabolism, University of Heidelberg, Heidelberg
关键词
APOLIPOPROTEIN-E; FAMILIAL DYSBETALIPOPROTEINEMIA; SECONDARY HYPOTHYROIDISM; TYPE-III HYPERLIPOPROTEINEMIA;
D O I
10.1111/j.1365-2796.1991.tb00428.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Post-surgical hypothyroidism developed in a now 43-year-old woman with complete insufficiency of the anterior pituitary gland who discontinued levothyroxine replacement therapy. Serum cholesterol and serum triglyceride levels increased in parallel, and classical type III hyperlipoproteinaemia (HLP) with xanthoma striata palmaris developed. The patient is homozygous for apolipoprotein (apo) E2. The case reported here represents the first example of manifestation of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apo E2/2 phenotype.
引用
收藏
页码:183 / 186
页数:4
相关论文
共 50 条
  • [21] Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype
    Shahmanesh, M
    Jaleel, H
    DeSilva, Y
    Ross, JDC
    Caslake, M
    Cramb, R
    SEXUALLY TRANSMITTED INFECTIONS, 2001, 77 (04) : 283 - 286
  • [22] TYPE-III HYPERLIPOPROTEINEMIA ASSOCIATED WITH APOLIPOPROTEIN-E PHENOTYPE-E3/3 - STRUCTURE AND GENETICS OF AN APOLIPOPROTEIN-E3 VARIANT
    RALL, SC
    NEWHOUSE, YM
    CLARKE, HRG
    WEISGRABER, KH
    MCCARTHY, BJ
    MAHLEY, RW
    BERSOT, TP
    JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04): : 1095 - 1101
  • [23] Type III hyperlipoproteinemia and increased susceptibility to atherosclerosis in human apolipoprotein E2 gene replacement mice
    Sullivan, PM
    Mezdour, H
    Maeda, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A348 - A348
  • [24] APOLIPOPROTEIN-EBETHESDA - A NEW VARIANT OF APOLIPOPROTEIN-E ASSOCIATED WITH TYPE-III HYPERLIPOPROTEINEMIA
    GREGG, RE
    GHISELLI, G
    BREWER, HB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (05): : 969 - 974
  • [25] Type III hyperlipoproteinemia and increased susceptibility to atherosclerosis in human apolipoprotein E2 gene replacement mice
    Sullivan, PM
    Mezdour, H
    Maeda, N
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 381 - 381
  • [26] APOLIPOPROTEIN E2-CHRISTCHURCH (136 ARG -] SER) - NEW VARIANT OF HUMAN APOLIPOPROTEIN-E IN A PATIENT WITH TYPE-III HYPERLIPOPROTEINEMIA
    WARDELL, MR
    BRENNAN, SO
    JANUS, ED
    FRASER, R
    CARRELL, RW
    JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (02): : 483 - 490
  • [27] APOLIPOPROTEIN-E1 PHENOTYPE ASSOCIATED WITH E1/E0 GENOTYPE AND SEVERE TYPE-III HYPERLIPOPROTEINEMIA
    LACKNER, KJ
    FEUSSNER, G
    VONHODENBERG, E
    ZIEGLER, R
    KUBLER, W
    ARTERIOSCLEROSIS, 1988, 8 (05): : A578 - A579
  • [28] ANALYTICAL ISOELECTRIC-FOCUSING, APOLIPOPROTEINS E3 AND E2 - DIAGNOSIS OF FAMILIAL TYPE-III HYPERLIPOPROTEINEMIA
    BRADY, D
    HYND, B
    MCNEELY, S
    STEIN, EA
    GLUECK, CJ
    CLINICAL RESEARCH, 1979, 27 (02): : A273 - A273
  • [29] APOLIPOPROTEIN E-III IS DEFICIENT IN FRESHLY SECRETED LIPOPROTEINS IN TYPE-III HYPERLIPOPROTEINEMIA (HLP)
    FALKO, JM
    WEIDMAN, SW
    WITZTUM, J
    SCHONFELD, G
    CLINICAL RESEARCH, 1979, 27 (02): : A365 - A365
  • [30] Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2
    Huang, Y
    Rall, SC
    Mahley, RW
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 2817 - 2824